Xsphera Biosciences Inc — Form D
Xsphera Biosciences Inc of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-16. The offering totals $3.0M, of which $100K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-06-16
- Form: D
- Accession: 0001934197-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $100K
- Remaining: $2.9M
- Investors: 1
- Date of first sale: 2022-05-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-449388
Issuer
- Name: Xsphera Biosciences Inc
- CIK: 0001934197
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 6 TIDE STREET, BOSTON, MA, 02110
- Phone: 6178323030
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Stephen Remondi | Director | Boston, MA |
| Stephen Remondi | Executive Officer | Boston, MA |
| Robert Walsh | Director | Bedford, TX |
Other filings by this issuer (1)
More